Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.31 +0.01 (+4.40%)
As of: Sep 10, 2026 · 10:36 AM EDT

Senti Biosciences Holdings (SNTI) Other Working Capital Changes (2021 - 2025)

Senti Biosciences Holdings (SNTI) posted Other Working Capital Changes of -$1.2 million for Q4 2025, down 3.19% on a QoQ basis from -$1.2 million in Q3 2025, and down 15.07% year-over-year from -$1.4 million in Q4 2024.

Analysis

Senti Biosciences Holdings (SNTI) Other Working Capital Changes (2021 - 2025) Analysis & Trends

Senti Biosciences Holdings has reported Other Working Capital Changes for 5 years, with the latest figure at -$1.2 million in Q4 2025.

  • On a quarterly basis, Other Working Capital Changes fell 15.07% year-over-year to -$1.2 million in Q4 2025; TTM through Dec 2025 was -$4.6 million, a 15.28% decrease from a year earlier, with the FY2025 full-year figure at -$4.6 million, down 15.28% from the prior year.
  • Other Working Capital Changes was -$1.2 million for Q4 2025 at Senti Biosciences Holdings, down from -$1.2 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $700000.0 in Q4 2022, with the low at -$734000.0 in Q3 2022.
  • Average Other Working Capital Changes over 3 years is -$295888.9, with a median of -$400000.0 recorded in 2021.
  • The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes surged 4765.57% in 2022, then sank 742.48% in 2024.
  • Over 5 years, Other Working Capital Changes stood at $61000.0 in 2021, then soared by 4765.57% to $3.0 million in 2022, then tumbled by 87.53% to $370000.0 in 2023, then plunged by 388.65% to -$1.1 million in 2024, then dropped by 15.07% to -$1.2 million in 2025.
  • The last three Other Working Capital Changes figures came in at -$1.2 million (Q4 2025), -$1.2 million (Q3 2025), and -$1.1 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.25 Bn 9.40 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.06 Bn 5.06 Bn -
3 Iovance Biotherapeutics 3.74 Bn 3.45 Bn 55.72 Mn
4 Legend Biotech 3.58 Bn 2.62 Bn 251.50 Mn
5 uniQure 3.01 Bn 3.01 Bn 5.49 Mn
6 Beam Therapeutics 2.54 Bn 2.54 Bn -
7 Precigen 2.37 Bn 2.37 Bn 52.17 Mn
8 Sarepta Therapeutics 2.21 Bn 1.42 Bn 251.87 Mn
9 Vericel 1.95 Bn 1.79 Bn 56.40 Mn
10 Senti Biosciences Holdings 9.61 Mn 9.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.23 Mn
Dec 31, 2025 -1.23 Mn
Sep 30, 2025 -1.19 Mn
Sep 30, 2025 -1.19 Mn
Jun 30, 2025 -1.13 Mn
Jun 30, 2025 -1.13 Mn
Mar 31, 2025 -1.09 Mn
Mar 31, 2025 -1.09 Mn
Dec 31, 2024 -1.07 Mn
Dec 31, 2024 -1.07 Mn
Sep 30, 2024 -1.03 Mn
Sep 30, 2024 -1.03 Mn
Jun 30, 2024 -983,000.00
Jun 30, 2024 -983,000.00
Mar 31, 2024 -946,000.00
Mar 31, 2024 -946,000.00
Dec 31, 2023 370,000.00
Dec 31, 2023 370,000.00
Sep 30, 2023 -921,000.00
Sep 30, 2023 -921,000.00